Status:

COMPLETED

A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides

Lead Sponsor:

Allergan

Conditions:

Facial Rhytides

Glabellar Rhytides

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This is a safety and efficacy study of onabotulinumtoxinA in subjects with upper facial rhytides (forehead lines, glabellar lines, lateral canthal lines \[crow's feet lines\]).

Eligibility Criteria

Inclusion

  • Moderate to severe forehead lines, glabellar lines, and crow's feet lines
  • Willing to have facial photos taken

Exclusion

  • Prior exposure to botulinum toxin of any serotype for any indication
  • Anticipated need for treatment with botulinum toxin of any serotype for any indication during the study, other than study treatment
  • Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, or amyotrophic lateral sclerosis
  • Any facial resurfacing laser or light treatment, microdermabrasion, or superficial peels in the past 3 months
  • Any medium depth or deep depth facial chemical peels; facial skin resurfacing; or permanent facial make-up in the past 6 months
  • Any nonpermanent soft tissue fillers, or treatment with oral retinoids in the past year - Prior face lift, thread lift, eyebrow lift, or related procedures (eg, eyelid and/or eyebrow surgery)
  • Prior facial treatment with permanent soft tissue fillers, synthetic implants (eg, Gore-Tex®), and/or fat transplantation

Key Trial Info

Start Date :

October 27 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 20 2016

Estimated Enrollment :

787 Patients enrolled

Trial Details

Trial ID

NCT02261493

Start Date

October 27 2014

End Date

April 20 2016

Last Update

July 25 2017

Active Locations (24)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (24 locations)

1

The Petrus Center for Aesthetic

Little Rock, Arkansas, United States, 72205

2

Westside Aesthetics

Los Angeles, California, United States, 90025

3

Eye Research Foundation

Newport Beach, California, United States, 92663

4

Steve Yoelin, MD Medical Associates, Inc.

Newport Beach, California, United States, 92663

A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides | DecenTrialz